No connection

Search Results

CC

BEARISH
$26.61 Live
The Chemours Company · NYSE
Target $21.67 (-18.6%)
$9.13 52W Range $26.65

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$3.99B
P/E
N/A
ROE
-93.8%
Profit margin
-6.6%
Debt/Equity
17.51
Dividend yield
1.32%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The Chemours Company exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and an alarming Debt/Equity ratio of 17.51. While the stock has seen a massive 1-year price surge of 119.6%, this momentum is decoupled from fundamentals, as evidenced by a negative ROE of -93.80% and shrinking revenue. The dividend is unsustainable with a payout ratio of 555.56%, and the current price of $26.61 already exceeds the analyst target price of $21.67. Overall, the company appears to be in a high-risk state with significant solvency concerns.

Key Strengths

Strong 1-year price momentum (+119.6%)
Low Price-to-Sales ratio (0.69) suggesting low valuation relative to revenue
Current ratio of 1.78 indicates adequate short-term liquidity
Positive operating margin (2.03%) despite negative net profit margin
Consistent history of beating earnings estimates in several quarters

Key Risks

Extreme leverage with a Debt/Equity ratio of 17.51
Critical financial health indicated by Piotroski F-Score of 2/9
Unsustainable dividend payout ratio of 555.56%
Severe erosion of equity reflected in ROE of -93.80% and P/B of 15.95
Negative revenue growth (-2.10% YoY) and crashing EPS growth (-54.5% YoY)
AI Fair Value Estimate
Based on comprehensive analysis
$20.5
-23.0% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
21
Weak
Value
30
Future
20
Past
40
Health
10
Dividend
5
AI Verdict
High Risk / Speculative
Key drivers: Extreme Debt/Equity, Piotroski F-Score 2/9, Negative ROE, Unsustainable Dividend
Confidence
90%
Value
30/100

Forward P/E of 11.60 looks attractive, but P/B suggests book value is nearly depleted.

Positives
  • Low P/S ratio
Watchpoints
  • Extreme P/B ratio (15.95)
  • Price exceeds analyst target price
Future
20/100

Growth metrics are trending downward across both revenue and earnings.

Positives
  • Recent price momentum
Watchpoints
  • Negative YoY revenue growth
  • Significant decline in YoY EPS growth
Past
40/100

Recent price action is a sharp outlier compared to long-term stagnation.

Positives
  • Strong 1Y and 6M price returns
Watchpoints
  • Volatile earnings surprises
  • Long-term 5Y change is nearly flat (+1.1%)
Health
10/100

Financial health is critical; the company is heavily over-leveraged.

Positives
  • Current ratio > 1.0
Watchpoints
  • Piotroski F-Score 2/9
  • Debt/Equity 17.51
  • ROE -93.80%
Dividend
5/100

Dividends are being paid from capital or debt rather than earnings.

Positives
  • Positive yield (1.32%)
Watchpoints
  • Payout ratio of 555.56% is fundamentally broken

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$26.61
Analyst Target
$21.67
Upside/Downside
-18.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CC and closest competitors.

Updated 2026-04-24
CC
The Chemours Company
Primary
5Y
+1.1%
3Y
+8.1%
1Y
+119.6%
6M
+91.7%
1M
+28.1%
1W
+14.8%
CBT
Cabot Corporation
Peer
5Y
+53.6%
3Y
+14.8%
1Y
-0.9%
6M
+9.1%
1M
+5.7%
1W
+3.2%
AAU
Allied Gold Corporation
Peer
5Y
+352.3%
3Y
+352.3%
1Y
+217.4%
6M
+81.2%
1M
-0.4%
1W
-0.7%
ARI
Aris Mining Corporation
Peer
5Y
+351.4%
3Y
+541.4%
1Y
+248.1%
6M
+90.1%
1M
+12.1%
1W
-7.7%
CGA
Centerra Gold Inc.
Peer
5Y
+134.1%
3Y
+188.7%
1Y
+184.3%
6M
+70.5%
1M
+12.0%
1W
-5.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
11.6
PEG Ratio
1.6
P/B Ratio
15.95
P/S Ratio
0.69
EV/Revenue
1.33
EV/EBITDA
12.12
Market Cap
$3.99B

Profitability

Profit margins and return metrics

Profit Margin -6.65%
Operating Margin 2.03%
Gross Margin 15.65%
ROE -93.8%
ROA 2.49%

Growth

Revenue and earnings growth rates

Revenue Growth -2.1%
Earnings Growth N/A
Q/Q Revenue Growth -4.59%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
17.51
High debt
Current Ratio
1.78
Good
Quick Ratio
0.8
Poor
Cash/Share
$4.46

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.3B
Gross Margin
11.7%
Op. Margin
-0.4%
Net Margin
-4.6%
Total Assets
$7.4B
Liabilities
$7.1B
Equity
$0.2B
Debt/Equity
28.52x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
67%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-19
$0.05
+192.1% surprise
2025-11-06
$0.2
-17.2% surprise
2025-08-05
$0.58
+26.9% surprise

Basic Materials Sector Comparison

Comparing CC against 109 companies in the Basic Materials sector (4 bullish, 41 neutral, 64 bearish)
Return on Equity (ROE)
-93.8%
This Stock
vs
-10.47%
Sector Avg
+796.2% (Excellent)
Profit Margin
-6.65%
This Stock
vs
-7.78%
Sector Avg
-14.6% (Weaker)
Debt to Equity
17.51
This Stock
vs
1.02
Sector Avg
+1621.7% (Higher)
Revenue Growth
-2.1%
This Stock
vs
38.21%
Sector Avg
-105.5% (Slower)
Current Ratio
1.78
This Stock
vs
5.92
Sector Avg
-70.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DIGNAM DENISE
Chief Executive Officer
Stock Award
2026-03-02
169,538 shares
WILL DAVID
Officer
Stock Award
2026-03-02
8,337 shares
WELLMAN KRISTINE M
General Counsel
Stock Award
2026-03-02
25,708 shares
FAMILIAR CALDERON GERARDO
Officer
Stock Award
2026-03-02
25,708 shares
MARTINKO JOSEPH T.
Officer
Stock Award
2026-03-02
28,488 shares
FOLEY MICHAEL ROBERT
Officer
Stock Award
2026-03-02
75,040 shares
HOSTETTER SHANE
Chief Financial Officer
Stock Award
2026-03-02
47,387 shares
DIGNAM DENISE
Chief Executive Officer
Stock Award
2026-02-24
2,261 shares
WELLMAN KRISTINE M
General Counsel
Stock Award
2026-02-24
1,781 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-03-12

Chemours Company (CC) filed an 8-K on March 12, 2026, likely to announce its fourth-quarter and full-year financial results.

DEF 14A
DEF 14A
2026-03-10

CC filed a definitive proxy statement (DEF 14A) on March 10, 2026, providing shareholders with necessary information to vote on corporate matters.

8-K
8-K
2026-02-26

Chewy, Inc. filed an 8-K on February 26, 2026, likely to announce its fourth-quarter and full-year financial results.

10-K
10-K
2026-02-24

CC filed its 10-K annual report on February 24, 2026, which includes sections on business operations, risk factors, and management's discussion and analysis. No specific financial highlights or risk details were provided in the available excerpts.

8-K
8-K
2026-02-19

Carnival Corporation filed an 8-K on February 19, 2026, likely to announce its financial results for the most recent fiscal period.

8-K
8-K
2026-01-16
10-Q
10-Q
2025-11-06

CC filed its 10-Q on November 6, 2025. While the filing includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk descriptions were provided in the available excerpt.

8-K
8-K
2025-11-06

Chewy, Inc. filed an 8-K on November 6, 2025, likely to announce its quarterly financial results.

8-K
8-K
2025-10-31

Chemours Company (CC) filed an 8-K on October 31, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-16

Chewy, Inc. filed an 8-K on October 16, 2025, likely to announce its quarterly financial results.

8-K
8-K
2025-09-03
8-K
8-K
2025-08-29
10-Q
10-Q
2025-08-05
8-K
8-K
2025-08-05
8-K
FORM 8-K
2025-08-04
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
9 analysts
UBS
2026-04-09
Maintains
Buy Buy
Truist Securities
2026-04-09
Maintains
Buy Buy
Mizuho
2026-03-05
Maintains
Outperform Outperform
Goldman Sachs
2026-02-25
Maintains
Neutral Neutral
UBS
2026-02-23
Maintains
Buy Buy
BMO Capital
2026-02-23
Maintains
Outperform Outperform
JP Morgan
2026-02-23
Maintains
Neutral Neutral
Morgan Stanley
2026-02-23
Maintains
Equal-Weight Equal-Weight
Truist Securities
2026-01-21
Maintains
Buy Buy
JP Morgan
2025-12-03
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning CC from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile